Most Cited Article Award
SOHEIL HADDADZADEGAN — Nanyang Technological University
Soheil Haddadzadegan of Nanyang Technological University, Singapore, is recognized in this Most Cited Article Award profile for research in Pharmacology. The recognized article, “Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers,” examines lipid-based nanocarrier technologies developed to address the challenges associated with the oral administration of therapeutic peptides and proteins.[1]
Abstract
This article presents Soheil Haddadzadegan in connection with the Most Cited Article Award for research in Pharmacology. The recognized publication examines the technology landscape of lipid-based nanocarriers for the oral delivery of therapeutic peptides and proteins. Because biological macromolecules can face substantial barriers during oral administration, lipid-based delivery systems have been investigated as potential platforms for improving protection, transport, absorption, and bioavailability. The article provides a technology-focused perspective on the development of lipid-based nanocarriers for oral peptide and protein delivery and highlights their relevance to pharmaceutical formulation and drug-delivery research.[1]
Keywords
Most Cited Article Award, Soheil Haddadzadegan, Pharmacology, Oral Drug Delivery, Therapeutic Peptides, Therapeutic Proteins, Lipid-Based Nanocarriers, Nanomedicine, Drug Delivery Systems, Pharmaceutical Technology, Oral Peptide Delivery, Protein Delivery, Bioavailability, Lipid Nanoparticles, Nanocarriers, Drug Formulation.[1]
Introduction
The oral delivery of therapeutic peptides and proteins represents an important challenge in pharmaceutical science because these molecules may experience degradation, limited permeability, and inefficient absorption within the gastrointestinal environment. Lipid-based nanocarriers have emerged as a technological approach for addressing some of these limitations by providing protective delivery environments and opportunities for improved transport across biological barriers. The recognized article examines the broader technology landscape surrounding lipid-based nanocarriers and their application to oral peptide and protein delivery.[1]
Research Profile
Soheil Haddadzadegan is affiliated with Nanyang Technological University in Singapore and is associated with research in Pharmacology. According to the supplied Scopus profile information, the researcher has 21 documents, 975 citations, and an h-index of 13. The Scopus Author ID associated with this profile is 57408006400. The researcher is also identified through ORCID record 0000-0002-8979-864X, providing a persistent identifier for distinguishing and connecting scholarly contributions across research systems.[2][3]
Research Contributions
The recognized research focuses on lipid-based nanocarriers as technological platforms for the oral administration of therapeutic peptides and proteins. Such delivery systems are investigated for their potential to protect sensitive biological molecules from adverse gastrointestinal conditions while supporting their transport and absorption. By examining the technology landscape, the publication contributes to understanding the formulation strategies, delivery challenges, and development opportunities associated with lipid-based systems for macromolecular therapeutics.[1]
Publication
The principal publication associated with this award profile is “Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.” The article addresses the development and technological landscape of lipid-based nanocarriers for oral delivery of peptide and protein therapeutics and is recognized here for its substantial scholarly citation impact in the field of Pharmacology.[1]
Research Impact
The research has demonstrated substantial scholarly visibility, with the supplied Scopus profile reporting 975 citations across 21 documents and an h-index of 13. The recognized article addresses a significant pharmaceutical delivery challenge and provides a technology-oriented perspective on lipid-based nanocarriers for therapeutic peptides and proteins. Its citation performance reflects continued scholarly interest in oral macromolecular drug delivery and nanocarrier-based pharmaceutical technologies.[1][2]
Award Recognition
Soheil Haddadzadegan is recognized in this Most Cited Article Award profile for the scholarly contribution represented by “Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.” The recognition highlights the article’s strong citation impact and its relevance to the development of advanced oral drug-delivery technologies for therapeutic peptides and proteins. The award profile acknowledges the publication’s contribution to Pharmacology and pharmaceutical nanotechnology research.[1][2]
Conclusion
Soheil Haddadzadegan of Nanyang Technological University, Singapore, is featured in this Most Cited Article Award profile for research in Pharmacology. The recognized publication explores the technology landscape of lipid-based nanocarriers for oral delivery of therapeutic peptides and proteins, addressing important challenges associated with the administration of biological therapeutics. With 975 citations, 21 documents, and an h-index of 13 according to the supplied Scopus information, the researcher demonstrates a notable scholarly impact within the research profile presented here.[1][2]
External Links
References
- Haddadzadegan, S. “Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.”
Recognized publication.
- Scopus. (n.d.). Scopus Author Profile: Soheil Haddadzadegan.
https://www.scopus.com/authid/detail.uri?authorId=57408006400
- ORCID. (n.d.). ORCID Profile: Soheil Haddadzadegan.
https://orcid.org/0000-0002-8979-864X
- Best Paper Awards. (n.d.).
https://bestpaperawards.com/